Pfizer has drugs in line to replace expired patents
301891
Pfizer Inc. is on schedule to complete the filing of 20 new drug applications by the end of 2006 as it confronts patent expirations affecting $14 billion in sales, CEO Hank McKinnell said Tuesday.
561495
Dec. 19--Pfizer, the world&#39;s biggest drug maker, and the rest of the pharmaceutical sector will come under renewed pressure this week after the Food and Drug Administration (FDA) warned doctors to consider
377721
Faced with the threat of generic competition, the company focuses its efforts on a new drug.
56941
Pfizer Inc.  on Friday said a Canadian federal court granted its request to prevent Novopharm Ltd. from launching a generic version of Pfizer's Lipitor cholesterol drug until a patent expires in July 2010.
217275
In the cold, calculating world of Wall Street, that&#39;s how the unfolding drama of new test results on old drugs is playing out, as analysts see bright spots for Pfizer (PFE:NYSE - news - research) amid other drugs&#39; woes.
20994
Pfizer plans to ask or approval of torcetrapib, a heart drug crucial to the companyÂs future, despite evidence that the drug increases blood pressure.
414734
Pfizer Inc.  said on Tuesday that it had won a patent case over its Lipitor drug in an Irish court, which ruled a patent protecting the blockbuster cholesterol fighter would be infringed by a competing product from India's Ranbaxy Laboratories Ltd.
607555
Proposed legislation could spell changes across the pharmaceutical world.
326752
Pfizer plans to ask for approval of torcetrapib, a heart drug crucial to the companyÂs future, despite evidence that the drug increases blood pressure.
745709
At a research and development meeting for analysts on Nov. 30, Pfizer (PFE ) stayed on message all day long. Despite questions about possible safety issues with arthritis pain medication Celebrex, patent challenges
54905
Pfizer Inc. PFE.N on Tuesday  reaffirmed it expects 2004 earnings to be more than 20 percent  above last year, but warned that results in 2005-2007 will be  hurt by patent expirations on over a half-dozen of its  best-selling medicines.
101354
A day after Whitehouse Station-based Merck abruptly withdrew from the market Vioxx, its blockbuster arthritis drug, Pfizer yesterday moved to promote Celebrex, its competing medicine.
483706
NeoPharm Inc., a biotechnology company developing cancer treatments, said it regained ownership of two cancer compounds after Pfizer Inc.
620499
Sales of its lead drug should expand in 2008.
422768
Pfizer reaffirmed its commitment today to Celebrex, its blockbuster prescription medication for pain and inflammation from arthritis.
296028
Pfizer Inc. , Merck &amp; Co. , and fellow drug makers thought Republican congressional majorities and President Bush's reelection created a firewall against legal prescription drug imports. The wall is starting to crack.
411558
The pharmaceutical sues over patent infringement.